Poles apart? nordic walking may outpace standard rehab for heart failure
NCT ID NCT02061319
First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time
Summary
This trial tests whether a 12-week Nordic walking program—walking with poles—improves exercise capacity and quality of life in people with heart failure better than standard cardiac rehabilitation. Participants attend twice-weekly sessions, and researchers measure walking distance, heart function, fitness, and well-being. The goal is to see if this simple, accessible exercise offers extra benefits for daily living.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Nordic walking (a form of walking with poles, as a behavioral exercise intervention)
- What this could lead to
- If Nordic walking proves superior, it could become a recommended exercise option to improve daily function and quality of life for people with heart failure.
- What could go wrong
- This is a small, early-stage trial, so results may not apply broadly. Nordic walking may not outperform standard rehab, and any exercise carries some risk for heart failure patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
77 people
The number who actually took part.
- Start date
-
Mar 2014
- Finished
-
Aug 2017
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patient has a confirmed diagnosis of HF based on a HF admission and/or a clear diagnosis of HF and/or reduced ejection fraction (≤45% measured by echocardiography within the last six months); * Patient is referred to cardiac rehabilitation program; * Patient is willing to attend an onsite cardiac rehabilitation program twice weekly for 12 weeks; * In the opinion of the referring physician, the patient is medically stable, and able to participate in an exercise program * Patient is able, in the opinion of the qualified investigator, to comprehend and participate in the exercise intervention; * Patient is 18 years of age or older; * Patient is willing to provide informed consent. Exclusion Criteria: * Patient is unable to read and understand English or French * Patient intends to begin cardiac rehabilitation within the next 6 weeks * Patient is unwilling or unable to return for follow-up visits at 12 and 26 weeks; * Patient is currently using Nordic Walking poles.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Heart failure are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Ottawa Heart Institute
Ottawa, Ontario, K1Y 4W7, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which SGLT2 inhibitor wins? trial pits empagliflozin against dapagliflozin
- Can daily mindful breathing ease heart failure symptoms?
- Can a smartphone app keep heart failure patients out of the hospital?
- Can better training get doctors to talk about what matters most to dying veterans?
- Can AI read heart ultrasounds as well as trained sonographers?
- Can modern heart failure drugs reverse damage in three months?